Cover Image
市場調查報告書

尋常型天皰瘡:全球臨床實驗檢討

Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318806
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
尋常型天皰瘡:全球臨床實驗檢討 Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 68 Pages
簡介

本報告提供尋常型天皰瘡的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 尋常型天皰瘡
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上尋常型天皰瘡所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上尋常型天皰瘡所佔的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

尋常型天皰瘡治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞 尋常型天皰瘡

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Kemia, Inc.
    • Jacobus Pharmaceutical Company
    • GlaxoSmithKline plc
    • Genzyme Corporation
    • F. Hoffmann-La Roche Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University Medical Center Groningen
    • Tehran University of Medical Sciences
    • The National Institute of Allergy and Infectious Diseases
    • University of Heidelberg
    • Shiraz University of Medical Sciences
    • Northwestern University
    • University Hospital, Toulouse
    • New York University School of Medicine
    • Massachusetts General Hospital
    • Philipps University Marburg Medical Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2403CTIDB

GlobalData's clinical trial report, "Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pemphigus Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pemphigus Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pemphigus Vulgaris
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Pemphigus Vulgaris to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pemphigus Vulgaris to Immunology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pemphigus Vulgaris
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pemphigus Vulgaris Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Pemphigus Vulgaris
    • Oct 07, 2014: Stiefel, a GSK company, announces start of phase III study of subcutaneous ofatumumab for pemphigus vulgaris
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Kemia, Inc.
      • Clinical Trial Overview of Kemia, Inc.
      • Jacobus Pharmaceutical Company
      • Clinical Trial Overview of Jacobus Pharmaceutical Company
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Genzyme Corporation
      • Clinical Trial Overview of Genzyme Corporation
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • University Medical Center Groningen
      • Clinical Trial Overview of University Medical Center Groningen
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • University Hospital, Toulouse
      • Clinical Trial Overview of University Hospital, Toulouse
      • New York University School of Medicine
      • Clinical Trial Overview of New York University School of Medicine
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Philipps University Marburg Medical Center
      • Clinical Trial Overview of Philipps University Marburg Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Region, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pemphigus Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Kemia, Inc., 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Philipps University Marburg Medical Center, 2014*

List of Figures

  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pemphigus Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top